• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    RenaissanceRe Holdings Ltd. Common Stock (NY:RNR)

    255.99 +1.90 (+0.75%)
    Official Closing Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about RenaissanceRe Holdings Ltd. Common Stock

    < Previous 1 2 3 Next >
    RenaissanceRe Reports $907.7 Million of Net Income Available to Common Shareholders and $733.7 million of Operating Income Available to Common Shareholders in Q3 2025.
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Schedules Third Quarter 2025 Financial Results Conference Call
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Quarterly Dividend and Renewal of Share Repurchase Program
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Reports $826.5 Million of Net Income Available to Common Shareholders and $594.6 million of Operating Income Available to Common Shareholders in Q2 2025.
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Schedules Second Quarter 2025 Financial Results Conference Call
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Quarterly Dividend and Renewal of Share Repurchase Program
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Reports $161.1 Million of Net Income Available to Common Shareholders and $69.8 million of Operating Loss Attributable to Common Shareholders in Q1 2025.
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Schedules First Quarter 2025 Financial Results Conference Call
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Launches New Property Catastrophe Bond Fund - Medici UCITS
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Pricing of $300 Million Senior Notes Offering by Joint Venture, DaVinciRe Holdings Ltd.
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Pricing of $500 Million Senior Notes Offering
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Thirtieth Consecutive Annual Increase in Quarterly Dividend and Renewal of Share Repurchase Program
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Reports $1.8 billion of Annual Net Income Available to Common Shareholders and $2.2 billion of Operating Income Available to Common Shareholders in 2024.
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Schedules Fourth Quarter and Year-End 2024 Financial Results Conference Call
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    Loretta J. Mester to Join RenaissanceRe Holdings Ltd. Board of Directors
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Quarterly Dividend and Increase of Share Repurchase Authorization to $750 million
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Reports $1.2 Billion of Net Income Available to Common Shareholders and $540.3 Million of Operating Income Available to Common Shareholders in Q3 2024.
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Schedules Third Quarter 2024 Financial Results Conference Call
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    AM Best Affirms Credit Ratings of RenaissanceRe Holdings Ltd. and Its Main Subsidiaries
    From AM Best
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Quarterly Dividend and Renewal of Share Repurchase Program
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Reports $495.0 Million of Net Income Available to Common Shareholders and $650.8 Million of Operating Income Available to Common Shareholders in Q2 2024.
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Schedules Second Quarter 2024 Financial Results Conference Call
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Quarterly Dividend and Renewal of Share Repurchase Program
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Reports $364.8 Million of Net Income Available to Common Shareholders and $636.4 Million of Operating Income Available to Common Shareholders in Q1 2024.
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Schedules First Quarter 2024 Financial Results Conference Call
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Twenty-Ninth Consecutive Annual Increase in Quarterly Dividend
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. (NYSE: RNR) Making Surprising Moves in Wednesday Session
    Via Investor Brand Network
    RenaissanceRe Reports $1.6 Billion of Quarterly Net Income Available to Common Shareholders and $623.1 Million of Quarterly Operating Income Available to Common Shareholders in Q4 2023.
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Schedules Fourth Quarter and Year-End 2023 Financial Results Conference Call
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    RenaissanceRe Holdings Ltd. Announces Quarterly Dividend
    From RenaissanceRe Holdings Ltd.
    Via Business Wire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.